Avg closing price
Price range

35 Ken Griffin Alnylam Pharmaceuticals Trades

Ken Griffin's position in Alnylam Pharmaceuticals is currently worth $36 Million. That's 0.04% of their equity portfolio (524th largest holding). The first Alnylam Pharmaceuticals trade was made in Q2 2013. Since then Ken Griffin bought shares 41 more times and sold shares on 41 occasions. The stake costed the investor $20.4 Million, netting the investor a gain of 76% so far.

Avg closing price
Price range
Increased shares by 973.2% (+74.9 Thousand shares) Q3 2022
Avg closing price $190.40
Price range $138.54 - $233.85
Increased shares by 265.0% (+5.59 Thousand shares) Q2 2022
Avg closing price $141.87
Price range $120.42 - $169.29
Sold 97.0% shares (-68.7 Thousand shares) Q1 2022
Avg closing price $152.35
Price range $127.18 - $173.91
Increased shares by 238.9% (+49.9 Thousand shares) Q4 2021
Avg closing price $185.86
Price range $159.56 - $209.29
Sold 46.4% shares (-18.1 Thousand shares) Q3 2021
Avg closing price $187.58
Price range $169.75 - $207.73
Sold 68.4% shares (-84.3 Thousand shares) Q2 2021
Avg closing price $146.46
Price range $128.63 - $176.89
Increased shares by 364.4% (+96.7 Thousand shares) Q1 2021
Avg closing price $150.49
Price range $126.83 - $175.69
Sold 64.0% shares (-47.2 Thousand shares) Q3 2020
Avg closing price $142.11
Price range $121.19 - $165.49
Sold 33.2% shares (-36.7 Thousand shares) Q2 2020
Avg closing price $134.81
Price range $104.21 - $156.44
Increased shares by 36.6% (+29.6 Thousand shares) Q1 2020
Avg closing price $115.43
Price range $93.12 - $133.99
Increased shares by 0.5% (+367 shares) Q4 2019
Avg closing price $99.70
Price range $74.51 - $124.23
Sold 91.7% shares (-886 Thousand shares) Q3 2019
Avg closing price $79.11
Price range $70.90 - $87.82
Increased shares by 7751.5% (+954 Thousand shares) Q2 2019
Avg closing price $76.72
Price range $65.86 - $92.79
Sold 58.5% shares (-17.3 Thousand shares) Q1 2019
Avg closing price $83.64
Price range $72.76 - $93.45
Sold 16.5% shares (-5.86 Thousand shares) Q4 2018
Avg closing price $76.92
Price range $62.67 - $88.33
Sold 3.3% shares (-1.21 Thousand shares) Q3 2018
Avg closing price $100.59
Price range $87.52 - $122.67
New holding (+36.7 Thousand shares) Q2 2018
Avg closing price $99.19
Price range $88.31 - $107.80
Sold -57.5 Thousand shares Q1 2018
Avg closing price $128.92
Price range $115.92 - $148.54
Increased shares by 27.2% (+12.3 Thousand shares) Q4 2017
Avg closing price $125.65
Price range $114.49 - $139.98
New holding (+45.2 Thousand shares) Q3 2017
Avg closing price $85.36
Price range $72.53 - $118.27

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!